MS&L on FDA Social Media Hearing Recap: Day 2 (11/13/09)

Article

MS&L's North American Healthcare Practice Director, MaryEllen O'Donohue, and New York Healthcare Practice Director, Kelly Dencker, recap Day 2 of FDA Social Media Hearings held in Washington, DC.

Related Videos
John M. Oldham, MD: A History of Personality Disorder Pathology
Franklin King, MD: Psychedelic Therapy History, Advances, and Hurdles
Robert Weinrieb, MD: Psychiatry-Hepatology Approach for Alcohol-Related Liver Disease
Etienne Sibille, PhD: Innovations in Cognitive Pathology
Katharine Phillips, MD: Various Treatments for Obsessive-Compulsive Disorders
Manish Jha, MD: Treatment Options for Treatment-Resistant Depression
Katharine Phillips, MD: Differences Between OCD, Body Dysmorphic Disorder
Brian Barnett, MD: Psychedelics Fitting into the SUDs Treatment Paradigm
© 2024 MJH Life Sciences

All rights reserved.